Doxazosin
- Product NDC
- 71335-2322
- 11-digit product format
- 713352322
- Labeler code
- 71335
- Product ID
- 71335-2322_1cd4f8a1-f363-41e9-a5a8-0bc17eb2fd7d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxazosin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA075580
- Marketing category
- ANDA
- Marketing start
- 2011-07-14
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Doxazosin
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DOXAZOSIN MESYLATE | 4 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 86P6PQK0MU |
| Rxcui | 197627 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71335-2322 | DOXAZOSIN TABLET [BRYANT RANCH PREPACK] | 101 | Current NDC, 4 package rows | 20240828_54549d19-6311-4dbb-8622-fd3e5440551a.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71335-2322-1 | 71335232201 | 100 TABLET in 1 BOTTLE (71335-2322-1) | 100 tablet | 2024-08-12 | No | No | Historical |
| 71335-2322-2 | 71335232202 | 30 TABLET in 1 BOTTLE (71335-2322-2) | 30 tablet | 2023-12-21 | No | No | Historical |
| 71335-2322-3 | 71335232203 | 60 TABLET in 1 BOTTLE (71335-2322-3) | 60 tablet | 2024-08-12 | No | No | Historical |
| 71335-2322-4 | 71335232204 | 90 TABLET in 1 BOTTLE (71335-2322-4) | 90 tablet | 2024-08-12 | No | No | Historical |